Mapanao, A. K., Busslinger, S. D., Mehta, A., Kegler, K., Favaretto, C., Grundler, P. V., . . . Müller, C. (2025). Preclinical investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for tumor-targeted alpha therapy. European Journal of Nuclear Medicine & Molecular Imaging, 52(4), 1383. https://doi.org/10.1007/s00259-024-07035-8
Chicago Style (17th ed.) CitationMapanao, Ana Katrina, et al. "Preclinical Investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for Tumor-targeted Alpha Therapy." European Journal of Nuclear Medicine & Molecular Imaging 52, no. 4 (2025): 1383. https://doi.org/10.1007/s00259-024-07035-8.
MLA (9th ed.) CitationMapanao, Ana Katrina, et al. "Preclinical Investigation of [149Tb]Tb-DOTATATE and [149Tb]Tb-DOTA-LM3 for Tumor-targeted Alpha Therapy." European Journal of Nuclear Medicine & Molecular Imaging, vol. 52, no. 4, 2025, p. 1383, https://doi.org/10.1007/s00259-024-07035-8.